More is not always better, and thoughtful protocol design often outperforms brute force approaches over time
The important caveat is that most robust clinical evidence for these medications - including the trials underpinning their UK regulatory approval - is based on longer-term use, typically 68 weeks or more
55 The phase 3 REDEFINE-3 trial will further assess the impact of cagrilinitide/semaglutide on major adverse cardiovascular events in people with obesity (with or without T2DM) and established CVD (clinical trial number NCT05669755
If you want the specific injection protocol, our team covers it in detail in our guide to how to inject BPC-157, how much to take, and when to expect results based on the indication being treated
With OptiMantra, clinics can: Build customizable peptide therapy templates tailored to wellness, performance, and aesthetic programs Link peptide prescriptions directly to labs, progress notes, and individualized treatment plans Track outcomes over time to optimize protocols and improve patient results Maintain clean, audit-ready documentation that supports compliance and operational efficiency As the most in-demand peptides of 2026 reshape patient expectations, clinics equipped with structured, data-driven systems are best positioned to grow